Biotech Companies in Boston

Overview

Greater Boston — anchored by Kendall Square in Cambridge — is the world's most concentrated life sciences cluster, housing over 2,400 biotech, pharmaceutical, genomics, medical device, and life sciences technology companies. This audience is enriched with life sciences sub-sector classification, funding stage and total capital raised, clinical pipeline stage where available, and academic or hospital affiliations (MIT, Harvard, MGH, Dana-Farber, Broad Institute). Executive and scientific leadership contacts include both business leadership (CEO, CFO, CSO) and operational decision-makers.

What's Included

• Company Identity: Company name, website, and Cambridge/Boston location
• Sub-Sector: Life sciences classification (biopharmaceutical, genomics/genomic medicine, medical device, diagnostics, digital health, CRO/CDMO, life sciences tools)
• Funding and Stage: Funding stage, total raised, and clinical pipeline stage (preclinical, Phase I/II/III, commercial)
• Affiliations: Academic and hospital spin-out affiliations (MIT, Harvard, Broad Institute, MGH, Dana-Farber)
• Contacts: CEO, CFO, CSO, VP R&D, and operational leadership with verified email and phone

Use Cases

Life Sciences Platform and CRO Sales

Contract research organizations, data platforms, clinical trial management systems, and regulatory compliance tools target Boston biotech companies at specific pipeline stages — preclinical companies have different needs than Phase III or commercial-stage organizations. Pipeline stage enrichment enables stage-appropriate outreach.

Lab Equipment and Reagent Sales

Scientific instrument vendors, lab automation providers, and reagent suppliers target Boston biotech companies by company stage and size. Early-stage companies are high-volume purchasers of consumables; growth-stage companies are capital equipment buyers. Funding data helps segment by purchasing power and procurement formality.

Boston Biotech Investor Deal Sourcing

Life sciences venture capital firms and crossover investors active in Boston can use funding stage and pipeline stage data to identify companies approaching the next funding milestone — preclinical companies nearing IND filing, Phase II companies approaching Phase III decisions — for proactive deal sourcing.

Scientific Recruiting and Talent Acquisition

Life sciences executive search firms and talent acquisition platforms can identify companies in active hiring phases — growth-stage companies post-funding, clinical-stage companies building commercial teams — using funding recency and headcount growth as hiring signal proxies.